Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31141631

Ibrutinib and Venetoclax for First-Line Treatment of CLL.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 May 30
First author
Jain N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2019 May 30;380(22):2169-2171. doi: 10.1056/NEJMe1904362.
    note
    Source null
    related pmid
    31141640
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2019 Sep;16(9):526-527. doi: 10.1038/s41571-019-0243-z.
    note
    Source null
    related pmid
    31213701
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Aug 22;381(8):788-789. doi: 10.1056/NEJMc1908754.
    note
    Source null
    related pmid
    31433936
    relationship
    Comment in

Authors and identifiers

  1. name
    Jain N
    type
    Author
  2. name
    Keating M
    type
    Author
  3. name
    Thompson P
    type
    Author
  4. name
    Ferrajoli A
    type
    Author
  5. name
    Burger J
    type
    Author
  6. name
    Borthakur G
    type
    Author
  7. name
    Takahashi K
    type
    Author
  8. name
    Estrov Z
    type
    Author
  9. name
    Fowler N
    type
    Author
  10. name
    Kadia T
    type
    Author
  11. name
    Konopleva M
    type
    Author
  12. name
    Alvarado Y
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Jain N
    type
    Author
  2. name
    Keating M
    type
    Author
  3. name
    Thompson P
    type
    Author
  4. name
    Ferrajoli A
    type
    Author
  5. name
    Burger J
    type
    Author
  6. name
    Borthakur G
    type
    Author
  7. name
    Takahashi K
    type
    Author
  8. name
    Estrov Z
    type
    Author
  9. name
    Fowler N
    type
    Author
  10. name
    Kadia T
    type
    Author
  11. name
    Konopleva M
    type
    Author
  12. name
    Alvarado Y
    type
    Author
bibliography ids
  1. nci-bib-e81b29948d7e3d005451ea43
book metadata
content sha256
0590c801e3cc134ed805ef72cc449d6ed09e8126c81a6b60d5decce38afd57fb
document type
citation
dois
  1. 10.1056/NEJMoa1900574
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:31141631
immutable id
pubmed:31141631@0590c801e3cc134ed805ef72cc449d6ed09e8126c81a6b60d5decce38afd57fb
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
22
name
The New England journal of medicine
nlm unique id
0255562
pages
2095-2103
volume
380
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2019 May 30;380(22):2169-2171. doi: 10.1056/NEJMe1904362.
    note
    Source null
    related pmid
    31141640
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2019 Sep;16(9):526-527. doi: 10.1038/s41571-019-0243-z.
    note
    Source null
    related pmid
    31213701
    relationship
    Comment in
  3. citation
    N Engl J Med. 2019 Aug 22;381(8):788-789. doi: 10.1056/NEJMc1908754.
    note
    Source null
    related pmid
    31433936
    relationship
    Comment in
outcomes validated
false
pmid
31141631
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
f8818780485a8472a05715a1182acc81de2ca410e7d265daf3746b4e7d3e396a
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 May 30
precision
day
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31141631/
title
Ibrutinib and Venetoclax for First-Line Treatment of CLL.

Preserved source evidence · Not medical advice